Frontier Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-140,948
Closed -$16.7M 273
2022
Q3
$16.7M Sell
140,948
-7,407
-5% -$876K 0.2% 161
2022
Q2
$21.2M Buy
148,355
+1,066
+0.7% +$152K 0.24% 147
2022
Q1
$25.4M Buy
+147,289
New +$25.4M 0.23% 146
2021
Q4
Sell
-97,098
Closed -$37.4M 278
2021
Q3
$37.4M Sell
97,098
-367,042
-79% -$141M 0.29% 123
2021
Q2
$109M Sell
464,140
-181,164
-28% -$42.6M 0.8% 30
2021
Q1
$84.5M Buy
645,304
+224,909
+53% +$29.5M 0.64% 47
2020
Q4
$43.9M Sell
420,395
-31,552
-7% -$3.3M 0.33% 121
2020
Q3
$32M Sell
451,947
-87,013
-16% -$6.16M 0.28% 126
2020
Q2
$34.6M Buy
538,960
+72,937
+16% +$4.68M 0.31% 117
2020
Q1
$14M Buy
+466,023
New +$14M 0.16% 166